The mRNA vaccine Technology Transfer Hub was established in response to the flagrant inequities in access to COVID-19 vaccines in low- and middle-income countries, especially in Africa. Formally established in July 2021, the Hub's purpose is to increase access to mRNA vaccines made closer to home by establishing manufacturing capacity using a technology transfer hub model to ensure sustainable vaccine security in future pandemics.

This video filmed in November 2021 provides an overview on the Hub's establishment. The partners include the World Health Organization (WHO), Medicines Patent Pool (MPP), Afrigen, Biovac, the South African Medical Research Council (SAMRC), Africa Centres for Disease Control and Prevention (Africa CDC), the Department of Science and Innovation, South Africa.

More information: [ Ссылка ]

свернуть